Webinar hosted on April 26, 2021.
Presenters: Laveena Munshi MD MSc, Stephanie Carlin PharmD, Beth Leung PharmD MsCI
Moderator: Brad Langford PharmD
Audience: Clinicians in all hospital settings (acute teaching, large community, small community)
- Summarize the data on the use of tocilizumab in patients with COVID-19
- Describe the recommended populations to receive tocilizumab
- Provide advice and considerations regarding secondary infections
- Discuss access and use of tocilizumab in the context of a shortage situation